NICE yes for Votrient, no to Avastin
February 23, 2011Sales and Marketing Cancer, GSK, GlaxoSmithKline, Kidney cancer, NICE, Roche, avastin, bevacizumab, breast cancer
NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient on the same day it gave a final negative decision to Roche’s …
Commissioning Board to spearhead NHS reforms
February 23, 2011GP consortia, Health and Social Care Bill, NHS, NHS Commissioning Board, NHS reforms, PCT clusters, PCTs, SHAs, Sir David Nicholson, pathfinder consortia
NHS chief executive Sir David Nicholson says the new NHS Commissioning Board will be the driving force behind the health …
Kieran Murphy to head up life sciences for GE Healthcare
February 23, 2011Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing
GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …
Contract research news in brief
February 23, 2011Research and Development Bioanalytical Systems, Evotec, Iris Pharma, Kancera, Kinaxo Biotechnologies, NSF International, Pharmalytica Services, iNovacia
Acquisitions by Evotec, Kancera and NSF International head our latest CRO news round-up, along with updates from BASi and Iris …
Sanofi partners on dengue vaccine awareness
February 22, 2011Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines
Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …
Scottish biotech ProStrakan sold for £292m
February 22, 2011Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech
Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …
Pharma must rethink manufacturing, says PwC
February 22, 2011Manufacturing and Production pharma manufacturing, pricewaterhousecoopers, pwC
The pharmaceutical industry needs to undertake a radical overhaul in its approach to manufacturing which at present is “inefficient, under-utilised …
AstraZeneca plans $150m plant in Russia
February 22, 2011Manufacturing and Production, Sales and Marketing AstraZeneca, Russia, emerging pharma markets, pharma manufacturing
AstraZeneca has become the latest drugmaker to announce the construction of a manufacturing facility in Russia to help sidestep possible …
Quality problems lead to short-term layoffs at Baxter Ireland
February 22, 2011Manufacturing and Production Dianeal, Extraneal, Ireland, Nutrineal, baxter, job cuts, manufacturing compliance, peritoneal dialysis
A contaminated production line at a facility in Ireland operated by Baxter Healthcare has resulted in 150 staff being laid …
James Christie joins Oxford BioMedica as manufacturing head
February 22, 2011Manufacturing and Production James Christie, Oxford BioMedica, appointment, manufacturing and production
UK gene therapy company Oxford BioMedica has appointed James Christie as its first head of manufacturing. It following the firm’s …
SHL to speak at Drug Delivery System Development and Lifecycle Management Requirements for Biologic Pharmaceuticals: Trends and Best Practices
February 22, 2011Manufacturing and Production auto injector, autoinjector, drug delivery, shl group
The 2011 DCAT Biologics Forum will focus on trends and best practices for subcutaneous biologic drug delivery systems featuring presentations …
Europe votes in new anti-counterfeit law
February 21, 2011Manufacturing and Production EFPIA, counterfeits, supply chain
The European Parliament has voted in favour of the Falsified Medicines Directive to help stop the flow of counterfeit medicines …
Four steps to turn around a flagging pharma brand
February 21, 2011Sales and Marketing MSI, branding, brands, marketing
The glamorous end of pharma marketing is undoubtedly around the launch of a new product. Everyone is excited and optimistic, …
Idea Pharma boosts UK and US teams
February 21, 2011Sales and Marketing IDEA Pharma, Jeff Frick, Michael Morgan-Curran, appointment, sales and marketing
Idea Pharma has made new appointments to its UK- and US-based teams
Astellas to commercialise new kidney cancer drug in Europe
February 21, 2011Sales and Marketing Astellas, Aveo Pharmaceuticals, Cancer, Kidney cancer, rcc, renal cell carcinoma, tivozanib
Astellas and Aveo Pharmaceuticals are to commercialise Aveo’s investigational kidney cancer drug tivozanib in Europe and the US. Aveo is …
J&J hit by another string of product recalls
February 21, 2011Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls
There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …
Merck KGaA sales soar
February 21, 2011Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro
Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …
Matt de Gruchy to lead Ogilvy Healthworld UK
February 18, 2011Medical Communications Matt de Gruchy, Ogilvy Healthworld UK, appointment, medical communications
Comms agency Ogilvy Healthworld UK has appointed Matt de Gruchy as chief executive. Matt is a 14 year veteran of …
Digital Pharma: Merck Serono sets up MS social network
February 18, 2011Medical Communications Digital Pharma blog, MS, Merck Serono, Movectro, Rebif, multiple sclerosis, social networking
Merck Serono has set up an international social network for multiple sclerosis patients, saying today’s pharma companies should go beyond …
Merck Serono halts Movectro European licence application
February 18, 2011Medical Communications, Sales and Marketing Cladribine, MS, Merck KGaA, Merck Serono, Movectro, fingolimod, gilenya, multiple sclerosis
Merck Serono has withdrawn its European licence application for multiple sclerosis drug Movectro. Movectro (cladribine) is a new oral treatment …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
